Thymus Neoplasms Clinical Trials

11 clinical trials for Thymus Neoplasms across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma — RECRUITING · PHASE1
• Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. — RECRUITING · PHASE3
• Study on Proton Radiotherapy of Thymic Malignancies — RECRUITING · NA
• Hypofractionated Adjuvant Radiotherapy for Thymic Epithelial Tumors — NOT_YET_RECRUITING · NA
• Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection — ACTIVE_NOT_RECRUITING · NA
• Sunitinib for Advanced Thymus Cancer Following Earlier Treatment — COMPLETED · PHASE2
• Thoracic OncoGeriatric Assessment (TOGA) Trials — COMPLETED
• Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases — TERMINATED · PHASE1
• Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies — COMPLETED · PHASE1
• Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma — OTHER · PHASE2
• 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma — WITHDRAWN · PHASE2

Refine this search